Torres John D 4
4 · LENNOX INTERNATIONAL INC · Filed Feb 5, 2025
Insider Transaction Report
Form 4
Torres John D
EVP, Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock, Par Value $0.01 Per Share
2025-02-04$259.56/sh+1,103$286,295→ 6,392 total - Disposition to Issuer
Common Stock, Par Value $0.01 Per Share
2025-02-04$582.41/sh−695$404,775→ 5,697 total - Sale
Common Stock, Par Value $0.01 Per Share
2025-02-04$582.59/sh−715$416,552→ 4,341 total - Sale
Common Stock, Par Value $0.01 Per Share
2025-02-04$584.06/sh−285$166,457→ 4,056 total - Exercise/Conversion
Non-qualified Stock Appreciation Right
2025-02-04−1,020→ 0 totalExercise: $328.65From: 2022-12-10Exp: 2028-12-10→ Common Stock, Par Value $0.01 Per Share (1,020 underlying) - Exercise/Conversion
Common Stock, Par Value $0.01 Per Share
2025-02-04$328.65/sh+1,020$335,223→ 5,289 total - Disposition to Issuer
Common Stock, Par Value $0.01 Per Share
2025-02-04$582.41/sh−641$373,325→ 5,056 total - Sale
Common Stock, Par Value $0.01 Per Share
2025-02-04$581.96/sh−787$458,003→ 3,269 total - Exercise/Conversion
Non-qualified Stock Appreciation Right
2025-02-04−1,103→ 1,104 totalExercise: $259.56From: 2023-12-09Exp: 2029-12-09→ Common Stock, Par Value $0.01 Per Share (1,103 underlying)
Footnotes (3)
- [F1]Reflects a weighted average sale price of $582.59 at prices ranging from $582.410 to $583.130 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]One third of the Stock Appreciation Rights became exercisable on 12/10/2022 and each year thereafter. The entire grant became fully exercisable on 12/10/2024.
- [F3]One third of the Stock Appreciation Rights became exercisable on 12/09/2023 and each year thereafter. The entire grant will become fully exercisable on 12/09/2025.